Skip to main content

Table 3 Results of Meta-analysis of diastolic blood pressure

From: Clinical and economic outcomes of hospital pharmaceutical care: a systematic review and meta-analysis

Study

| SMD

[95% Conf. Interval]

% Weight

Carter (1997) [8]

| 0.110

−0.439

0.660

8.55

Carter (2009) [15]

| -0.108

−0.304

0.087

18.74

Schumacher (2018)

| -0.654

−0.884

−0.424

17.58

Korcegez (2017)

| -0.584

−0.908

−0.259

14.37

Domingues (2017) [40]

| -0.285

−0.715

0.144

11.27

Javaid (2019) [42]

| -0.402

−0.752

−0.052

13.57

Shao (2017)

| -0.203

−0.482

0.075

15.91

D + L pooled SMD

| -0.329

−0.532

−0.125

100.00

  1. Heterogeneity chi-squared =18.35 (d.f. = 6) p = 0.005.
  2. I-squared (variation in SMD attributable to heterogeneity) = 67.3%.
  3. Estimate of between-study variance Tau-squared = 0.0476.
  4. Test of SMD = 0: z = 3.17 p = 0.002.
  5. The significance level of the combined effect quantity test: 0.05.
  6. The significance level of the heterogeneity test: 0.1.
  7. Heterogeneity test: p > 0.1, no heterogeneity was considered; p < 0.1, heterogeneity was considered.